NW-301 TCR-T in Patients With Advanced Solid Tumor
NCT06956261
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Tumor, Solid
Interventions
DRUG:
NW-301V
DRUG:
Drug: NW-301D
Sponsor
Peking University